EFMC Sponsored Events are scientific events or post-graduate educational activities related to Medicinal Chemistry or Chemical Biology organised by EFMC national adhering organisations*, EFMC partner organisations, non-for-profit associations or scientific committees.
Applications for sponsorship should be done by sending the below form to the EFMC Administrative Secretariat (email@example.com), at least three months prior to the event for both physical and online events. In case of smaller online events, we will accept requests up to a month prior to the event.
Sponsorship applications will be considered by the EFMC Executive Committee before approval. Sponsorship will not be granted to events overlapping with EFMC organised events.
*EFMC national adhering organisations are granted EFMC sponsorships at no costs, provided the event fulfills the requirements.
Mastering Medicinal Chemistry VII is the latest in an ongoing series of conferences intended to provide expert advice and guidance to new practitioners in the field of drug discovery. It has been said that “there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems”. Anticipating and preparing for such problems thus accelerates the delivery of new medicines: this event will feature presentations from experienced ‘drug-hunters’ in both industry and academia, who will talk about the challenges faced in modern drug discovery, and will share best practice common to all successful medicinal chemists.
Date: Wednesday 22nd March 2023
Venue: Burlington House, London, United Kingdom
- Early bird registration deadline: 30th January, 2023 17:00(GMT)
- Registration deadline: 10th March, 2023, 17:00 (GMT)
- Nadia Ahmad (Charles River)
- Dave Alker (Dave Alker Associates)
- Rose Bardell-Cox (Evotec)
- Andrew Stachulski (University of Liverpool)
- Asier Unciti-Broceta (University of Edinburgh)
Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain. This symposium, the 7th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.
Date: Monday – Tuesday, 27th-28th March 2023
Venue: Hinxton Hall, Wellcome Genome Campus, Cambridge, United Kingdom
- Early bird registration: 30th January, 2023
- Karl Collins (Bayer Foundation)
- Brian Cox (University of Sussex)
- Sarah Major (Evotec)
- Nigel Swain (Heptares)
- Rose Bardell-Cox (Evotec)
- Mike Clegg (MSD)
- Nadia Ahmad (Charles River)
Known colloquially as the “Hatfield MedChem” meeting, this is a highly successful, long-standing, one-day meeting that runs annually. The scientific program will comprise presentations showcasing medicinal chemistry case studies from tools to candidates, across a range of modalities, therapeutic areas and target classes, as well as covering more general topics at the forefront of drug discovery. The meeting aims to be informal and interactive, and is ideal for all those working in medicinal chemistry and drug discovery more widely.
Date: Thursday, 27th April 2023
- Nicole Hamblin (Charles River)
- Adrian Hall (UCB)
- David Hirst (MSD)
The University of Siena and the Department of Biotechnology Chemistry & Pharmacy (Department of Excellence 2018-2022) announces the 9th Edition of the European Workshop in Drug Synthesis (EWDSy) for researchers from Universities and Pharmaceutical Industries.
The 9th Edition of the EWDSy will cover various topics in medicinal chemistry and drug synthesis, including bioconjugation techniques and antibody drug conjugates, antimicrobial resistance, green and sustainable approaches in medicinal chemistry.
Date: 21st-24th May 2023
Venue: Certosa di Pontignano, Siena, Italy
Abstract Submission Deadline: 31st March 2023
- Elena Petricci
- Lorenzo Botta University of Viterbo
- Stefano Sainas University of Torino
- Daniele Castagnolo University College London
This 2.5 day symposium is the third in the very successful series of biannual meetings started in 2017 containing high quality international speakers from industry and academia on topics of Medicinal Chemistry and related enabling technologies. Organised by the Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry, together with Nordic affiliates, the meeting promises to be an exciting and invigorating gathering packed with fantastic opportunities to disseminate knowledge and expand networks.
Programme Themes and Features
The scientific programme will feature themed lectures, focusing on medicinal chemistry and related new enabling technologies and disciplines across a range of drug targets and modalities. A distinguishing feature of this symposium is the collegiate style with the delegates living at the premises which encourages an atmosphere of information sharing and learning.
Please find the list of Speakers on the website.
Registration is open, and you may register via this link.
- Oral Abstracts: 31st January, 2023
- Eary Bird & Poster Abstracts: 24th March, 2023
- Bursary Application: 3rd May, 2023
- Standard Registration: 5th June, 2023
- Sharan Bagal (AstraZeneca, United Kingdom) - Chair
- Kevin Dack (LEO Pharma, Denmark)
- Adrian Hall (UCB, Belgium)
- Malin Lemurell (AstraZeneca, Sweden)
- Anette Graven Sams (Lundbeck, Denmark)
- Morten Jørgensen (LEO Pharma, Denmark)
The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) is pleased to invite you to Lille, France on July 5-7, 2023 for the 57th edition of the International Conference on Medicinal Chemistry (RICT 2023).
The congress will be devoted to “Drug Discovery and Selection” and the main topics will be:
Next Generation of Anti-infective Agents
Small Molecules for Cancer or Autoimmunity
New Avenues in Drug Discovery Chemistry
New Molecular Landscapes in Drug Discovery
Case studies in Selected Therapeutic Areas
Late-Breaking Topics: First Disclosures of Clinical Candidates
As for previous editions of RICT, the scientific committee will ensure the high quality and diversity of the scientific programme together with the accessibility of the meeting to PhD/post-doc and local Master students. For the latter, an advantageous registration fee will be proposed. Moreover, a special career session will be organised with industrial and academic participants.
We look forward welcoming you in Lille!
The Organising Committee
- Société de Chimie Thérapeutique (SCT) (France)